AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

The Australian investors shelling out to back Blackpearl
Markets

The Australian investors shelling out to back Blackpearl

Institutional investors with billions under management have taken stakes in an NZ firm.

A cut to the milk price isn’t as bad as it sounds
Primary Sector

A cut to the milk price isn’t as bad as it sounds

A $9.50/kgMS price is still well ahead of breakeven.

Pacific Edge looks to US comeback after half-year loss
Markets

Pacific Edge looks to US comeback after half-year loss

The company says it has never been in a stronger position to regain Medicare coverage.

Contact Energy chief fires election-year warning
Markets

Contact Energy chief fires election-year warning

Fuge urges stability as Contact leans into a big build.